← Leaderboards
Bo Zhao
Brigham And Women'S Hospital
$7,274,065
Attributed
$7,495,940
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,495,940 · 3
By mechanism
R01$7,495,940 · 3
Top collaborators
- Elliott D Kieff1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Elliott D Kieff$27,601,410
- Frederick C. Wang$16,331,006
- Benjamin Elison Gewurz$12,892,911
- Chong Wang$1,369,010
- Eric C Johannsen$4,978,414
Others in their field
Top investigators on “Growth”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$233,131,631
- Albert Lazzarini · California Institute Of Technology$170,110,000
- David H Reitze · University Of Florida$170,110,000
- Garret A Fitzgerald · University Of Pennsylvania$153,184,124
- David Heimbrook · Leidos Biomedical Research, Inc.$143,966,408
- Carol Nesel · Westat$116,355,411
Research focus
GrowthImmuneSiteMolecularProliferatingHuman Herpesvirus 4Lymphoproliferative DisordersRestInsightMembrane ProteinsLymphoblastLymphomaProteinsEpstein-Barr Virus Nuclear AntigensCellsGenetic TranscriptionGene ExpressionEnhancersGenesB-LymphocytesLymphoblastoid Cell LineProteomicsIn VitroNovel Therapeutics
Grant awards (16)
Targeting Epstein-Barr Virus Super-Enhancer$447,500
R01 · FY2025 · AI · contact PI
Targeting Epstein-Barr Virus Super-Enhancer$447,500
R01 · FY2024 · AI · contact PI
Targeting Epstein-Barr Virus Super-Enhancer$447,500
R01 · FY2023 · AI · contact PI
Targeting Epstein-Barr Virus Super-Enhancer$447,500
R01 · FY2022 · AI · contact PI
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation$532,500
R01 · FY2021 · CA · contact PI
Targeting Epstein-Barr Virus Super-Enhancer$447,500
R01 · FY2021 · AI · contact PI
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation$532,500
R01 · FY2020 · CA · contact PI
Targeting Epstein-Barr Virus super-enhancers$443,750
R01 · FY2020 · AI · contact PI
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation$516,527
R01 · FY2019 · CA · contact PI
Targeting Epstein-Barr Virus super-enhancers$443,750
R01 · FY2019 · AI · contact PI
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation$532,500
R01 · FY2018 · CA · contact PI
Targeting Epstein-Barr Virus super-enhancers$443,750
R01 · FY2018 · AI · contact PI
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation$532,500
R01 · FY2017 · CA · contact PI
Targeting Epstein-Barr Virus super-enhancers$443,750
R01 · FY2017 · AI · contact PI
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation$393,163
R01 · FY2017 · CA · contact PI
Targeting Epstein-Barr Virus super-enhancers$443,750
R01 · FY2016 · AI